Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Prevention of Postoperative Cognitive Dysfunction in Cardiac Surgery
NCT02782429Phase 4Unknown
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) and delirium comparing Ketamine with Placebo (2 arms). Primary endpoints: Change in cognitive disorder defined by MMSE drop at 7 days and Detectable levels of inflammatory biomarkers in bloodstream at 24 hours. Status: unknown.
02
Drugs
ketamine
03
Conditions
Post-operative cognitive dysfunction (POCD)delirium
Beyond the preview
Go deeper on NCT02782429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782429.